Assessment of allodynia and hyperalgesia after cisplatin administration to rats

Neuroscience Letters

Volumn 291, Issue 2, 2000, Pages 73-76

  Authier, Nicolas ^a   Fialip, Joseph ^a   Eschalier, Alain ^a   Coudoré, François ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Cisplatin; Neurotoxicity; Nociception; Peripheral neuropathy; Sensory function

Indexed keywords

CISPLATIN;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HYPERALGESIA; MALE; NEUROTOXICITY; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT;

ANIMALS; CISPLATIN; HEAT; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; MALE; NEURONS, AFFERENT; PAIN; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SKIN; STRESS, MECHANICAL;

EID: 0034665995     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01373-2     Document Type: Article

References (20)

1. Authier N., Coudoré F., Eschalier A., Fialip J. Pain related behaviour during vincristine-induced neuropathy in rats. NeuroReport. 10:1999;965-968.
2. Barajon I., Bersani M., Quartu M., Del Fiacco M., Cavaletti G., Holst J.J., Tredici G. Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp. Neurol. 138:1996;93-104.
3. Bogliun G., Marzorati L., Cavaletti G., Frattola L. Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione. Ital. J. Neurol. Sci. 13:1992;643-647.
4. Boyle F.M., Wheeler H.R., Shenfield G.M. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J. Neuro-Oncol. 41:1999;107-116.
5. Cavaletti G., Marzorati L., Bogliun G., Colombo N., Marzola M., Pittelli M.R., Tredici G. Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity. Cancer. 69:1992;203-207.
6. Cavaletti G., Petruccioli M.G., Tredici G., Marmiroli P., Barajon I., Fabbrica D., Di Francesco A. Effects of repeated administration of low doses of cisplatin on the rat nervous system. Int. J. Tissue React. 13:1991;151-157.
7. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 53:1994;55-63.
8. De Koning P., Neijt J.P., Jennekens F.G.I., Gispen W.H. Evaluation of cis-Diamminedichloroplatinum (II) (Cisplatin) neurotoxicity in rats. Toxicol. Appl. Pharmacol. 89:1987;81-87.
9. Gerritsen van der Hoop R., Hamers F.P.T., Neijt J.P., Veldman H., Gispen W.H., Jennekens F.G.I. Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence. J. Neurol. Sci. 126:1994;109-115.
10. Gispen W.H., Hamers F.P.T., Vecht C.J., Jennekens F.G.I., Neyt J.P. ACTH/MSH like peptides in the treatment of cisplatin neuropathy. J. Steroid. Biochem. Molec. Biol. 43:1992;179-183.
11. Hamers F.P.T., Pette C., Bravenboer B., Vecht C.J., Neijt J.P., Gispen W.H. Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766. Cancer Chemother. Pharmacol. 32:1993;162-166.
12. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
13. Hol E.M., Mandys V., Sodaar P., Gispen W.H., Bär P.R. Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glia cells in vitro. J. Neurosci. Res. 39:1994;178-185.
14. Necker P., Hellon R.F. Noxious thermal input from the rat tail: modulation by descending inhibitory influences. Pain. 4:1978;231-242.
15. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflammed tissue. Arch. Int. Pharmacodyn. 61:1957;409-419.
16. Siegal T., Haim N. Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps. Cancer. 66:1990;1117-1123.
17. Thompson S.W., Davis L.E., Kornfeld M., Hilgers R.D., Standefer J.C. Cisplatin neuropathy. Cancer. 54:1984;1269-1275.
18. Verdù E., Vilches J.J., Rodriguez F.J., Ceballos D., Valero A., Navarro X. Physiological and immunohistochemical characterization of cisplatin-induced neuropathy in mice. Muscle Nerve. 22:1999;329-340.
19. Yamamoto M., Kachi T., Yamada T., Nagamatsu M., Sobue G. Sensory conduction study of cisplatin neuropathy: preservation of small myelinated fibers. Int. Med. 36:1997;829-833.
20. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.